Impact of the Presence and Proportion of GGO on Survival and Pathological Characteristics in Clinical Stage I Lung Adenocarcinoma

被引:0
|
作者
Katsumata, S. [1 ]
Aokage, K. [2 ]
Ishii, G. [3 ]
Nakasone, S. [1 ]
Miyoshi, T. [1 ]
Tane, K. [1 ]
Tsuboi, M. [1 ]
机构
[1] Natl Canc Ctr Hosp East, Thorac Surg, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
关键词
lung adenocarcinoma; ground-glass opacity; consolidation-to-tumor ratio;
D O I
10.1016/j.jtho.2019.08.1141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.13-04
引用
收藏
页码:S547 / S547
页数:1
相关论文
共 50 条
  • [31] Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components
    Li, Ying
    Zhao, Junfeng
    Zhao, Ying
    Li, Ruyue
    Dong, Xue
    Yao, Xiujing
    Xia, Zhongshuo
    Xu, Yali
    Li, Yintao
    CANCER MEDICINE, 2024, 13 (03):
  • [32] Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study
    Zhixin Huang
    Dinghang Chen
    Zhinuan Hong
    Mingqiang Kang
    BMC Pulmonary Medicine, 23
  • [33] Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer
    Aokage, Keiju
    Miyoshi, Tomohiro
    Ishii, Genichiro
    Kusumoto, Masahiro
    Nomura, Shogo
    Katsumata, Shinya
    Sekihara, Keigo
    Tane, Kenta
    Tsuboi, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 533 - 542
  • [34] Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study
    Huang, Zhixin
    Chen, Dinghang
    Hong, Zhinuan
    Kang, Mingqiang
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [35] Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification
    Fan, Xiaohong
    Zhang, Xueyan
    Wang, Huimin
    Jin, Bo
    TUMOR BIOLOGY, 2014, 35 (06) : 5905 - 5910
  • [36] Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection
    Gao, Mao-Gang
    Wang, Shi-Ze
    Han, Kai-Hong
    Xie, Shao-Nan
    Liu, Qing-Yi
    NEOPLASMA, 2022, 69 (06) : 1480 - 1489
  • [37] Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
    Zhai, Wenyu
    Liang, Dachuan
    Duan, Fangfang
    Wong, Wingshing
    Yan, Qihang
    Gong, Li
    Lai, Renchun
    Dai, Shuqin
    Long, Hao
    Wang, Junye
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Prognostic Importance of Volumetric Measurements in Stage I Lung Adenocarcinoma
    Yanagawa, Masahiro
    Tanaka, Yuko
    Leung, Ann N.
    Morii, Eiichi
    Kusumoto, Masahiko
    Watanabe, Shunichi
    Watanabe, Hirokazu
    Inoue, Masayoshi
    Okumura, Meinoshin
    Gyobu, Tomoko
    Ueda, Ken
    Honda, Osamu
    Sumikawa, Hiromitsu
    Johkoh, Takeshi
    Tomiyama, Noriyuki
    RADIOLOGY, 2014, 272 (02) : 557 - 567
  • [39] Predicting pathological grade of stage I pulmonary adenocarcinoma: a CT radiomics approach
    Huang, Xiaoni
    Xue, Yang
    Deng, Bing
    Chen, Jun
    Zou, Jiani
    Tan, Huibin
    Jiang, Yuanliang
    Huang, Wencai
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study
    Bertoglio, Pietro
    Ventura, Luigi
    Aprile, Vittorio
    Cattoni, Maria Angela
    Nachira, Dania
    Lococo, Filippo
    Rodriguez Perez, Maria
    Guerrera, Francesco
    Minervini, Fabrizio
    Gnetti, Letizia
    Lenzini, Alessandra
    Franzi, Francesca
    Querzoli, Giulia
    Rindi, Guido
    Bellafiore, Salvatore
    Femia, Federico
    Bogina, Giuseppe Salvatore
    Bacchin, Diana
    Kestenholz, Peter
    Ruffini, Enrico
    Paci, Massimiliano
    Margaritora, Stefano
    Imperatori, Andrea Selenito
    Lucchi, Marco
    Ampollini, Luca
    Terzi, Alberto Claudio
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 35 (01)